Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sick Leave | 4 | 2020 | 110 | 2.520 |
Why?
|
Prostatic Neoplasms | 17 | 2024 | 11124 | 1.600 |
Why?
|
Insurance, Disability | 2 | 2019 | 26 | 1.220 |
Why?
|
Sweden | 9 | 2020 | 1345 | 0.920 |
Why?
|
Pensions | 2 | 2020 | 15 | 0.880 |
Why?
|
DNA Repair-Deficiency Disorders | 1 | 2021 | 29 | 0.810 |
Why?
|
Prostatectomy | 4 | 2020 | 1890 | 0.740 |
Why?
|
Women, Working | 1 | 2018 | 87 | 0.590 |
Why?
|
Prostate | 4 | 2023 | 1774 | 0.570 |
Why?
|
Watchful Waiting | 1 | 2020 | 492 | 0.530 |
Why?
|
Breast Neoplasms | 4 | 2022 | 20822 | 0.430 |
Why?
|
DNA Repair | 1 | 2021 | 2046 | 0.420 |
Why?
|
Lymph Node Excision | 1 | 2018 | 1261 | 0.400 |
Why?
|
Occupational Diseases | 1 | 2019 | 1471 | 0.370 |
Why?
|
Erectile Dysfunction | 1 | 2014 | 461 | 0.370 |
Why?
|
Drug Prescriptions | 2 | 2021 | 1637 | 0.350 |
Why?
|
Genetic Predisposition to Disease | 4 | 2023 | 17446 | 0.290 |
Why?
|
Organic Anion Transporters | 1 | 2024 | 100 | 0.230 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2022 | 107 | 0.190 |
Why?
|
Follow-Up Studies | 6 | 2024 | 39050 | 0.170 |
Why?
|
Fanconi Anemia | 1 | 2021 | 319 | 0.170 |
Why?
|
Male | 20 | 2024 | 350118 | 0.160 |
Why?
|
Melanoma | 2 | 2014 | 5510 | 0.160 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 426 | 0.160 |
Why?
|
Multifactorial Inheritance | 2 | 2022 | 1194 | 0.160 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 3255 | 0.150 |
Why?
|
Food Supply | 1 | 2023 | 524 | 0.150 |
Why?
|
Risk Factors | 7 | 2023 | 72290 | 0.150 |
Why?
|
Cohort Studies | 6 | 2024 | 40561 | 0.140 |
Why?
|
Seminal Vesicles | 1 | 2016 | 101 | 0.140 |
Why?
|
Humans | 26 | 2024 | 744343 | 0.130 |
Why?
|
Receptors, Progesterone | 1 | 2020 | 1097 | 0.130 |
Why?
|
Genome-Wide Association Study | 3 | 2023 | 12261 | 0.130 |
Why?
|
Prediabetic State | 1 | 2020 | 499 | 0.120 |
Why?
|
Middle Aged | 9 | 2022 | 213383 | 0.120 |
Why?
|
Prostate-Specific Antigen | 2 | 2022 | 2494 | 0.120 |
Why?
|
Databases, Factual | 2 | 2019 | 7729 | 0.110 |
Why?
|
Radiotherapy | 1 | 2020 | 1533 | 0.110 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2014 | 255 | 0.110 |
Why?
|
Receptors, Estrogen | 1 | 2020 | 2187 | 0.100 |
Why?
|
Biopsy | 1 | 2024 | 6756 | 0.100 |
Why?
|
Mastectomy | 1 | 2020 | 1793 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2020 | 1524 | 0.100 |
Why?
|
Age of Onset | 1 | 2018 | 3271 | 0.100 |
Why?
|
Feeding Behavior | 1 | 2023 | 3188 | 0.090 |
Why?
|
Life Style | 1 | 2022 | 3835 | 0.090 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2416 | 0.090 |
Why?
|
Age Factors | 2 | 2022 | 18370 | 0.080 |
Why?
|
Cause of Death | 1 | 2019 | 3584 | 0.080 |
Why?
|
Postoperative Care | 1 | 2014 | 1486 | 0.080 |
Why?
|
Aged | 6 | 2022 | 163280 | 0.070 |
Why?
|
Risk Assessment | 3 | 2023 | 23338 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2023 | 15519 | 0.070 |
Why?
|
Dementia | 1 | 2020 | 2518 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11031 | 0.070 |
Why?
|
Anxiety | 1 | 2020 | 4297 | 0.070 |
Why?
|
Registries | 3 | 2020 | 8089 | 0.060 |
Why?
|
Prognosis | 3 | 2022 | 29063 | 0.060 |
Why?
|
Preoperative Care | 1 | 2014 | 2250 | 0.060 |
Why?
|
Survival Analysis | 1 | 2018 | 10252 | 0.060 |
Why?
|
Adult | 6 | 2023 | 214055 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2020 | 4245 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2014 | 5686 | 0.060 |
Why?
|
Androgen Antagonists | 2 | 2024 | 1377 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2022 | 57776 | 0.050 |
Why?
|
Puerto Rico | 1 | 2023 | 356 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5751 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2022 | 21746 | 0.050 |
Why?
|
Female | 6 | 2020 | 380194 | 0.050 |
Why?
|
Depression | 1 | 2020 | 7766 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11524 | 0.040 |
Why?
|
Mental Disorders | 1 | 2019 | 6600 | 0.040 |
Why?
|
Early Detection of Cancer | 2 | 2023 | 3086 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 35421 | 0.040 |
Why?
|
Androgens | 1 | 2024 | 1281 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1581 | 0.030 |
Why?
|
Time Factors | 1 | 2016 | 40075 | 0.030 |
Why?
|
Death Certificates | 1 | 2014 | 169 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12354 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 20947 | 0.030 |
Why?
|
Cost of Illness | 1 | 2023 | 1859 | 0.030 |
Why?
|
Population Surveillance | 1 | 2023 | 2616 | 0.030 |
Why?
|
Emotions | 1 | 2023 | 2661 | 0.020 |
Why?
|
Young Adult | 2 | 2014 | 56430 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 12951 | 0.020 |
Why?
|
Adolescent | 2 | 2014 | 85781 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9687 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6256 | 0.020 |
Why?
|
United States | 2 | 2023 | 69872 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5319 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6538 | 0.010 |
Why?
|
Blood Chemical Analysis | 1 | 1965 | 440 | 0.010 |
Why?
|
Quality Control | 1 | 1965 | 841 | 0.010 |
Why?
|
Biometry | 1 | 1965 | 558 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 53288 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1965 | 2373 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 29786 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 63114 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 77449 | 0.010 |
Why?
|
Pregnancy | 1 | 2014 | 29144 | 0.010 |
Why?
|
Concepts
(101)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_